Ghost Tree Capital’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-22,500
| Closed | -$5.47M | – | 52 |
|
|
2024
Q2 | $5.47M | Sell |
22,500
-37,500
| -63% | -$9.11M | 1.71% | 22 |
|
|
2024
Q1 | $8.97M | Buy |
60,000
+32,500
| +118% | +$4.86M | 2.48% | 10 |
|
|
2023
Q4 | $5.26M | Buy |
+27,500
| New | +$5.26M | 1.72% | 11 |
|
|
2022
Q3 | – | Sell |
-1,900
| Closed | -$277K | – | 36 |
|
|
2022
Q2 | $277K | Buy |
+1,900
| New | +$277K | 0.14% | 29 |
|
|
2022
Q1 | – | Sell |
-30,000
| Closed | -$5.09M | – | 41 |
|
|
2021
Q4 | $5.09M | Buy |
+30,000
| New | +$5.09M | 1.82% | 17 |
|
|
2019
Q3 | – | Sell |
-150,000
| Closed | -$10.9M | – | 42 |
|
|
2019
Q2 | $10.9M | Hold |
150,000
| – | – | 2.26% | 10 |
|
|
2019
Q1 | $14M | Buy |
150,000
+115,000
| +329% | +$10.7M | 3.66% | 8 |
|
|
2018
Q4 | $2.55M | Sell |
35,000
-140,000
| -80% | -$10.2M | 0.93% | 26 |
|
|
2018
Q3 | $15.3M | Sell |
175,000
-35,000
| -17% | -$3.06M | 3.26% | 9 |
|
|
2018
Q2 | $20.7M | Buy |
+210,000
| New | +$20.7M | 6.09% | 5 |
|
|
2017
Q4 | – | Sell |
-35,000
| Closed | -$4.11M | – | 45 |
|
|
2017
Q3 | $4.11M | Buy |
+35,000
| New | +$4.11M | 0.87% | 32 |
|
|
2016
Q1 | – | Sell |
-45,000
| Closed | -$4.24M | – | 45 |
|
|
2015
Q4 | $4.24M | Buy |
+45,000
| New | +$4.24M | 1.73% | 24 |
|
|
2015
Q3 | – | Sell |
-90,000
| Closed | -$10.8M | – | 71 |
|
|
2015
Q2 | $10.8M | Buy |
90,000
+50,000
| +125% | +$5.99M | 3.5% | 5 |
|
|
2015
Q1 | $4.18M | Sell |
40,000
-15,000
| -27% | -$1.57M | 1.5% | 23 |
|
|
2014
Q4 | $5.34M | Buy |
55,000
+20,000
| +57% | +$1.94M | 2.56% | 8 |
|
|
2014
Q3 | $2.73M | Sell |
35,000
-40,000
| -53% | -$3.12M | 1.48% | 25 |
|
|
2014
Q2 | $4.74M | Buy |
+75,000
| New | +$4.74M | 3.34% | 7 |
|